Navigation Links
Array BioPharma Announces Exercise Of Underwriters' Option To Purchase An Additional $17.25 Million Of 3.00% Convertible Senior Notes
Date:6/7/2013

BOULDER, Colo., June 7, 2013 /PRNewswire/ -- Array BioPharma Inc. (NasdaqGM: ARRY) announced today that the underwriters in its previously announced offering of 3.00% Convertible Senior Notes Due 2020 exercised in full their option to purchase an additional $17.25 million in aggregate principal amount of notes. Including the full exercise of the option, Array will issue a total of $132.25 million in aggregate principal amount of 3.00% Convertible Senior Notes Due 2020. Array anticipates that its aggregate net proceeds from the offering will be $128.0 million after deducting the underwriting discount and estimated offering expenses payable by Array, and expects to use approximately $92.6 million of the net proceeds to repay its outstanding secured indebtedness, with the remaining proceeds expected to be used for general corporate purposes. Goldman, Sachs & Co. and J.P. Morgan Securities LLC are acting as joint book-running managers for the offering, and Piper Jaffray & Co. and Stifel, Nicolaus & Company, Incorporated are acting as co-managers.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

The notes will be general senior unsecured obligations of Array. The notes will bear interest at a rate of 3.0% per year, payable semi-annually, and will mature on June 1, 2020. The notes will be convertible by the holders beginning March 1, 2020, or earlier upon specified events, and upon conversion, the holders will receive, at Array's option, shares of Array's common stock, cash or a combination of shares and cash. The notes will be convertible at an initial conversion rate of 141.8641 shares per $1,000 in principal amount of notes, equivalent to a conversion price of approximately $7.05 per share. Array may redeem some or all of the notes for cash under certain circumstances on or after June 4, 2
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
6. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
7. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... SAN DIEGO , March 30, 2015 /PRNewswire/ ... announced that Tom Cannell has joined ... for global commercialization of Contrave® /Mysimba™ (naltrexone HCl ... all aspects of Orexigen,s global commercial strategy, assuming ... After successfully leading Orexigen,s commercial effort through the ...
(Date:3/30/2015)... , March 30, 2015  New York College ... world class Intellectual Properties portfolio with U.S. Patent #8,996,098 ... policy. This patent represents a surgical instrument that allows ... as if it were in the traditional format of ... it against medical databases during surgery, thus providing the ...
(Date:3/30/2015)... , March 30, 2015 Sorrento Therapeutics, Inc. ... George K. Ng to the position of ... capacity, Mr. Ng will be responsible for all legal, ... joins the Company from BioDelivery Sciences International, Inc., where ... a member of senior management that led that company ...
Breaking Medicine Technology:Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3
(Date:3/30/2015)... March 30, 2015 Dr. Jeff Farmer now ... , The mini implant is placed into the bone, usually ... is fitted and snapped into place. For those having trouble ... implants could be the solution. Thousands of patients around the ... without any adhesives. It is all made possible by mini ...
(Date:3/30/2015)... Columbus, OH (PRWEB) March 30, 2015 ... in product liability lawsuits, notes that the number of ... federal multidistrict litigation underway in U.S. District Court, District ... established in December 2014. "According to an update released ... on March 16th, at least 493 Syngenta lawsuits are ...
(Date:3/30/2015)... New York (PRWEB) March 30, 2015 ... been filed in California Superior Court on behalf of ... heart birth defect after his mother was prescribed the ... to the March 6th filing in Alameda Superior Court, ... nausea and vomiting that she experienced in the early ...
(Date:3/30/2015)... 30, 2015 On March 11, 2015, Elle ... Away Fat,” details six new treatment options for dealing with ... one is a topical product. The other three technologies use ... Liposonix ) or freezing cold ( CoolSculpting ) to kill ... now available to us to permanently remove unwanted fat," says ...
(Date:3/30/2015)... In a recent report published by ... is championing effective drug and alcohol treatment for victims ... recover funds to stabilize the addiction treatment programs, and ... drug and alcohol addiction. Harbor Village Detox is extending ... use disorders in New Jersey, in hopes to help ...
Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3
... services rendered to Scotland children, could soon come to an ... out by ministers. // Dental practices in Scotland yield a ... number of registered NHS patients. ,There exists a ... such extra payments, says the British Dental Association (BDA). This ...
... study and found that the rates have increased among those who ... getting their children immunized with the three-in-one MMR jab in Scotland. ... level of 95% by the age of two. But there was ... due to the vaccines association with the childhood autism disease. ...
... newly developed bird flu vaccine would soon be launched ... national pharmaceutical agency //. The Prime Minister, Ferenc Gyurcsany, ... the much dreaded bird flu, last year. Vaccine trials ... results. The bird flu vaccine is claimed to confer ...
... of researchers from Warwick Medical School found that premature babies ... ,The study included 120,000 children born between 1983 and ... low birth weight and were born premature are more often ... include those that were born before 34 weeks. The findings ...
... patients at the Siteman Cancer Center are a part ... the School of Medicine's Medical Photography, Illustration and Computer ... Matters," invites patients and their families to paint a ... than 400 tiles have been painted in this manner. ...
... a local clinic now you can take a simple test ... ,Chlamydia is the most common sexually transmitted infection in the ... on to others without knowing. However, complications may occur if ... in both men and women., ,The Preventx kits are ...
Cached Medicine News:Health News:Children In Scotland Denied Access To Dental Care 2Health News:Home Chlamydia Test 2
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
QuantumPlex is a bead kit for multiple analyte-detection research applications in flow cytometry. The beads may be analyzed with any standard cytometer and do not require the use of specialized softw...
... OptiMAL® assay is a sensitive, ... that permits the detection of ... malaria; and can distinguish between ... P. vivax . In ...
Medicine Products: